4PACK A M,GIDAL B Y,VAZQUEZ B.Bone disease associated with antiepileptic drugs[J].Cleve Clin J Med,2004,71(Suppl 2):S42-48.
5REIFE R,PLEDGER G,WU S C.Topiramate as add-on therapy:pooled analysis of randomized controlled trials in adults[J].Epilepsia,2000,41(Suppl 1):S66-71.
6VALIMAKI M J,TIIHONEN M,LAITINEN K,et al.Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on anti-epileptic drugs[J].J Bone Miner Res,1994,9(5):631-637.
7SATO Y,KONDO I,ISHIDA S,et al.Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy[J].Neurology,2001,57(3):445-449.
8FARHAT G,YAMOUT B,MIKATI M,et al.Effect of antiepileptic drug on bone density in ambulatory patients[J].Neurology,2002,58(2/3):1348-1353.
9Khan SH, Wright SL, Banigesh A, et al. Antiischemic effects of topiramate in a transient global forebrain ischemia model: a neurochemical, histological, and behavioral evaluation. Neurochem Res,2003, 28(8 ) : 1235-1239.
10Morris RG, Garrud P, Rawlins JN, et al. Place navigation impaired in rats with hippocampal lesions. Nature, 1982, 297:681-683.
2Flores Santos R, Hernandez-Cabrera MA, Hen6ndez-Herrera RJ, et al. Screening for retinopathy of prematurity : results of a 7-year study of underweight newborns. Arch Med Res, 2007, 38:440- 443.
3Wallace DK, Veness-Meehan KA, Miller WC, et al. Incidence of severe retinopathy of prematurity before and after a modest reduction in target oxygen saturation levels. J AAPOS, 2007, 11 : 170-174.
4Yang C, Lafleur J, Mwaikambo BR, et al. Lysophosphatidic acid receptor (LPA1) in the oxygen-induced retinal ganghon cell degeneration. Invest Ophthalmol Vis Sci, 2009, 50:1290-1298.
5Darlow BA, Hutchinson JL, Henderson-Smart D J, et al. Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand neonatal network. Pediatrics, 2005, 115:990-996.
6Zhou X,Li F, Ge J, et al. Retinal ganglion cell protection by 17- beta-estradiol in a mouse model of inherited glaucoma. Dev Nearobiol, 2007, 67:603-616.
7Yao M,Nguyen TV, Pike CJ. Estrogen regulates Bcl-w and Bim expression: role in protection against beta-amyloid peptide- induced neuronal death. J Neurosci, 2007, 27 : 1422-1433.
8Brann DW, Dhandapani K, Wakade C, et al. Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids, 2007, 72 : 381-405.
9Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest, 2006, 116:561-570.
10Manthey D, Behl C. From structural biochemistry to expression profiling : neuroprotective activities of estrogen. Neuroscience, 2006, 138:845-850.
